Scientific Consulting Offers Independence And Flexibility

In 1976, biochemist Fred Rothstein, of Long Beach, Calif., decided that he had "too much of an entrepreneurial personality to deal with the structure of corporate or academic life." Rothstein, whose experience included 20 years teaching physiology at Tufts University Medical School and five years as an industrial scientist with Miles Laboratories and Abbott Laboratories, struck out on his own and became a consultant to pharmaceutical and biotechnology companies. Since then, he says, he has earn

Written byIlene Schneider
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

In 1976, biochemist Fred Rothstein, of Long Beach, Calif., decided that he had "too much of an entrepreneurial personality to deal with the structure of corporate or academic life." Rothstein, whose experience included 20 years teaching physiology at Tufts University Medical School and five years as an industrial scientist with Miles Laboratories and Abbott Laboratories, struck out on his own and became a consultant to pharmaceutical and biotechnology companies. Since then, he says, he has earned "enough to put two children through Eastern colleges and one through medical school."

Gary Anderson, 41, whose career path also includes experience in both industry and academia, says he regarded consulting as "a natural sequence" when he founded his business, Tres-Ark Inc. in Edina, Minn., a year and a half ago. Anderson, whose six-person firm helps companies bring particle technology to the marketplace by providing sales, marketing, and technical support, says consulting fees of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies